IS6980A - 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum - Google Patents

3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum

Info

Publication number
IS6980A
IS6980A IS6980A IS6980A IS6980A IS 6980 A IS6980 A IS 6980A IS 6980 A IS6980 A IS 6980A IS 6980 A IS6980 A IS 6980A IS 6980 A IS6980 A IS 6980A
Authority
IS
Iceland
Prior art keywords
diazabicyclo
preparations
antithrombotic compounds
antithrombotic
compounds
Prior art date
Application number
IS6980A
Other languages
English (en)
Inventor
Barnwell Neil
Björe Annika
Cheema Lal
Cladingboel David
Herring Adam
Lövqvist Karin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6980A publication Critical patent/IS6980A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IS6980A 2001-04-12 2003-10-08 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum IS6980A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms
PCT/SE2002/000725 WO2002083688A1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds

Publications (1)

Publication Number Publication Date
IS6980A true IS6980A (is) 2003-10-08

Family

ID=20283783

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6980A IS6980A (is) 2001-04-12 2003-10-08 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum

Country Status (29)

Country Link
US (1) US7217708B2 (is)
EP (2) EP1389213B1 (is)
JP (1) JP2004525970A (is)
KR (1) KR20030087078A (is)
CN (1) CN1269823C (is)
AR (1) AR035452A1 (is)
AT (1) ATE323095T1 (is)
BR (1) BR0208829A (is)
CA (1) CA2443470A1 (is)
CZ (1) CZ20032760A3 (is)
DE (1) DE60210598T2 (is)
DK (1) DK1389213T3 (is)
EE (1) EE200300504A (is)
ES (1) ES2261721T3 (is)
HU (1) HUP0303487A3 (is)
IL (1) IL158250A0 (is)
IS (1) IS6980A (is)
MX (1) MXPA03009206A (is)
NO (1) NO20034527L (is)
NZ (1) NZ528560A (is)
PL (1) PL367179A1 (is)
PT (1) PT1389213E (is)
RU (1) RU2286993C2 (is)
SE (1) SE0101327D0 (is)
SK (1) SK12572003A3 (is)
TW (1) TWI237025B (is)
UA (1) UA74629C2 (is)
WO (1) WO2002083688A1 (is)
ZA (1) ZA200307759B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259836B (en) * 2001-04-12 2006-08-11 Astrazeneca Ab Modified release formulation suitable for antiarrhythmic compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
WO2006135316A1 (en) * 2005-06-13 2006-12-21 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
AR053901A1 (es) * 2005-06-20 2007-05-23 Astrazeneca Ab Formas fisicas de oxabispidinas n,n'- disustituidas
MX2007016496A (es) * 2005-06-20 2008-03-06 Astrazeneca Ab Proceso para la preparacion de oxabispidinas n-n' -disustituidas.
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
WO2007103970A2 (en) * 2006-03-07 2007-09-13 Endacea, Inc. Compositions and methods for treating respiratory disorders
MX2009000286A (es) 2006-06-26 2009-03-20 Procter & Gamble Inhibidores de prolil hidroxilasa y metodos de uso.
NO2686520T3 (is) 2011-06-06 2018-03-17
MX2013014310A (es) 2011-06-06 2014-01-23 Akebia Therapeutics Inc Compuestos y composiciones para estabilizar el factor-2 alfa inducible por hipoxia como un metodo para tratar el cancer.
CN114404414A (zh) 2013-06-13 2022-04-29 阿克比治疗有限公司 用于治疗贫血症的组合物和方法
KR102495018B1 (ko) 2013-11-15 2023-02-06 아케비아 테라퓨틱스 인코포레이티드 ｛[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노｝아세트산의 고체형, 이의 조성물 및 용도
EP3247355A4 (en) 2015-01-23 2018-06-13 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
EA036920B1 (ru) 2015-04-01 2021-01-15 Экебиа Терапьютикс, Инк. Композиции и способы для лечения анемии
TW202406895A (zh) 2018-05-09 2024-02-16 美商阿克比治療有限公司 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法
US12304905B2 (en) 2019-03-28 2025-05-20 1ST Biotherapeutics, Inc. Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9902268D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
IL158250A0 (en) 2004-05-12
NO20034527D0 (no) 2003-10-09
CA2443470A1 (en) 2002-10-24
EE200300504A (et) 2003-12-15
CZ20032760A3 (cs) 2004-01-14
TWI237025B (en) 2005-08-01
US7217708B2 (en) 2007-05-15
KR20030087078A (ko) 2003-11-12
NO20034527L (no) 2003-12-10
HUP0303487A3 (en) 2005-04-28
ES2261721T3 (es) 2006-11-16
RU2003129231A (ru) 2005-04-10
DK1389213T3 (da) 2006-07-10
ATE323095T1 (de) 2006-04-15
DE60210598T2 (de) 2007-02-08
HK1061026A1 (en) 2004-09-03
ZA200307759B (en) 2005-01-03
EP1389213A1 (en) 2004-02-18
WO2002083688A1 (en) 2002-10-24
HUP0303487A2 (hu) 2004-01-28
SK12572003A3 (sk) 2004-07-07
PL367179A1 (en) 2005-02-21
RU2286993C2 (ru) 2006-11-10
EP1550663A1 (en) 2005-07-06
DE60210598D1 (de) 2006-05-24
CN1269823C (zh) 2006-08-16
CN1514837A (zh) 2004-07-21
NZ528560A (en) 2005-05-27
MXPA03009206A (es) 2004-01-29
US20040143000A1 (en) 2004-07-22
JP2004525970A (ja) 2004-08-26
AR035452A1 (es) 2004-05-26
UA74629C2 (en) 2006-01-16
BR0208829A (pt) 2004-03-09
EP1389213B1 (en) 2006-04-12
SE0101327D0 (sv) 2001-04-12
PT1389213E (pt) 2006-07-31

Similar Documents

Publication Publication Date Title
IL160708A0 (en) 1, 6-naphthyridine derivatives as antidiabetics
DE60111734D1 (de) [1,4']-bipiperidin verbindungen
NO20040540L (no) 4-amino-6-fenylpyrrolo[2,3-D]pyrimidinderivater.
ZA200108530B (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents.
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
IS6980A (is) 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
MXPA03009361A (es) Compuestos de urea utilies como agentes anti-inflamatorios.
MXPA03005433A (es) Compuestos de heterociclilalquilindol o-azaindol como ligandos de 5-hidroxitriptamina-6.
PT1210349E (pt) Pirazolo-¬4,3-d|-pirimidinas
ZA200203799B (en) Antithrombotic compound.
ZA200206779B (en) Solid formulation.
IS6989A (is) 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum
IS6990A (is) 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum
GB0130553D0 (en) 1,4-Dihydro-1,4-diphenylpyridine derivitives
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
MXPA03001263A (es) Formulacion fungicida.
AU2002331972A1 (en) 3,4-methylenedioxy-substituted chalcones as therapeutic agents
MXPA03000664A (es) Derivados n-sustituidos del acido 1-amino-1, 1-dialquilcarboxilico.
AU6390001A (en) 6,10-dimethyl-5,9-undecadien-2-ol
AU2002361027A1 (en) Substituted 1,5-diaminopentan-3-ol compounds
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
SI1389213T1 (sl) 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
PL352760A1 (en) Oxathiepino[6,5-b
EG23305A (en) Preparation of 1,2-dicloroethane.